Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.

Hope, R L; Weltman, M; Dingley, J; Fiatarone, J; Hope, A H; Craig, P I; Grierson, J M; Bilous, M; Williams, S J; Farrell, G C

Hope, R L; Weltman, M; Dingley, J; Fiatarone, J; Hope, A H; Craig, P I; Grierson, J M; Bilous, M; Williams, S J; Farrell, G C.

Affiliation

Hope RL; Department of Gastroenterology, Westmead Hospital, Sydney, NSW.

Med J Aust ; 162(1): 8-11, 1995 Jan 02.

Article in En | MEDLINE | ID: mdl-7845310

Subject(s)

Hepatitis B/therapy; Hepatitis, Chronic/therapy; Interferon-alpha/therapeutic use; Adult; Alanine Transaminase/blood; Biopsy; DNA, Viral/blood; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B/diagnosis; Hepatitis B/epidemiology; Hepatitis, Chronic/diagnosis; Hepatitis, Chronic/epidemiology; Humans; Interferon alpha-2; Liver/pathology; Male; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Time Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Hepatitis B / Hepatitis, Chronic Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Med J Aust Year: 1995 Document type: Article Country of publication: Australia

Search on Google

Add to My VHL

XML

PubMed Links